Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease
Biomolecules · 2025
DOI: 10.3390/biom15101367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Kazuya Igarashi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8585, Japan. Hauptthemen laut MEDLINE: Placenta Growth Factor, Alzheimer Disease, White Matter. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MHLW Research on Dementia Program, Japan Society for the Promotion of Science (JSPS) KAKENHI.
Themen: Demenz
Abstract (Originalsprache)
Autopsy studies have shown that Alzheimer’s disease (AD) often coexists with cerebrovascular injury, affecting cognitive outcomes and the effectiveness of anti-amyloid-beta (Aβ) drugs. No fluid biomarkers of cerebrovascular injury have been identified yet. We investigated the association between white matter hyperintensities (WMH) severity and fluid biomarkers, including cerebrospinal fluid (CSF) neurofilament light chain and plasma placental growth factor (PlGF) levels. This study included 242 patients from memory clinics. Magnetic resonance imaging (MRI), CSF, and plasma samples were collected. Patients were classified as AD+ or non-AD based on the CSF Aβ42/Aβ40 ratio. In the discovery cohort (79 AD+ and 20 non-AD patients with 3D-T1 images), we analyzed the association between WMH volume and plasma PlGF. In the validation cohort (54 AD+ patients without 3D-T1 images), we analyzed the association between WMH grading and plasma PlGF. Among AD+ patients in the discovery cohort, plasma PlGF levels remained significantly associated with WMH volume and grading after adjusting for age, sex, and global cognition. Among the AD+ patients in the validation cohort, the high-PlGF (above median) group had significantly greater WMH volumes and a higher number of patients with a high WMH grading than the low-PlGF (below median) group. Plasma PlGF is a promising marker of cerebrovascular injury in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
- Department of Neurology, Brain Research Institute, Niigata University, Niigata 951-8585, Japan.
- Department of Neurosurgery, Niigata Rinko Hospital, Niigata 950-8725, Japan.
- Department of Neurosurgery, Niigata Neurosurgical Hospital, Niigata 950-1101, Japan.
- Department of Geriatric Medicine, Tokyo Medical University, Tokyo 160-8402, Japan.
- Department of Diagnostic Innovation Science, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
ORCID-Profile: Tamao Tsukie, Akinori Miyashita, Osamu Onodera, Takeshi Ikeuchi, Kensaku Kasuga
Förderung
- MHLW Research on Dementia Program
- Japan Society for the Promotion of Science (JSPS) KAKENHI
Zitieren
APA
Igarashi, K., Tsukie, T., Washiyama, K., Onda, K., Miyagi, Y., Inagawa, S., Shimizu, S., Miyashita, A., Onodera, O., Ikeuchi, T., & Kasuga, K. (2025). Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease. Biomolecules. https://doi.org/10.3390/biom15101367
Vancouver
Igarashi K, Tsukie T, Washiyama K, Onda K, Miyagi Y, Inagawa S, et al. Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease. Biomolecules. 2025. doi:10.3390/biom15101367
BibTeX
@article{Igarashi2025,
author = {Igarashi, Kazuya and Tsukie, Tamao and Washiyama, Kazuo and Onda, Kiyoshi and Miyagi, Yuki and Inagawa, Shoya and Shimizu, Soichiro and Miyashita, Akinori and Onodera, Osamu and Ikeuchi, Takeshi and Kasuga, Kensaku},
title = {Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15101367}
}
EUVIMED